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Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of Probion Forte® when used in feed for chickens for fattening. Probion Forte® is a
preparation containing viable spores of a strain of Bacillus subtilis and Bacillus coagulans intended for
use in feed for chickens for fattening at the minimum dose of 1 9 108 and a maximum of
2 9 108 colony-forming units (CFU)/kg feedingstuffs. In the view of the FEEDAP Panel, the identity of
the bacterial strains is established as B. subtilis and B. coagulans and their susceptibility to relevant
antibiotics is demonstrated. However, both bacterial strains belong to species capable of producing
toxins. The absence of a toxigenic potential has not been demonstrated and, therefore, these strains
do not qualify for a qualiﬁed presumption of safety (QPS) approach to safety assessment and separate
studies on target animals and consumer safety are required. The data provided did not allow
concluding on the safety for chickens for fattening or the consumers. Probion Forte® is not a skin or
eye irritant but should be considered a potential respiratory sensitiser. No conclusion can be drawn on
the skin sensitisation potential of the additive. In the absence of evidence that the two active agents
are not toxigenic, Probion Forte® is considered as a hazard for those handling the additive. Probion
Forte® is considered safe for the environment. The FEEDAP Panel is not in the position to conclude on
the efﬁcacy of Probion Forte® for chickens for fattening from the data provided.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from WooGene B&G Co., Ltd.2 for authorisation of
the product Probion Forte®, Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P, when
used as a feed additive for chickens for fattening, chickens reared for laying and laying hens
(category: zootechnical additive; functional group: gut ﬂora stabiliser). During the assessment, the
applicant requested a change in the species by withdrawing the request for authorisation for chickens
reared for laying and laying hens.3
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 4 May 2015.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P), when
used under the proposed conditions of use (see Section 3.1.4).
1.2. Additional information
The additive Probion Forte® is a preparation of spores of one strain of Bacillus subtilis and one of
Bacillus coagulans. This product has not been previously authorised in the EU.
The species B. subtilis and B. coagulans are considered by EFSA to be suitable for the qualiﬁed
presumption of safety (QPS) approach to establishing safety for the target species, consumers and the
environment (EFSA, 2007; EFSA BIOHAZ Panel, 2013). This approach requires the identity of the
strains to be conclusively established and evidence that the strains lack of toxigenic potential and do
not show resistance to antibiotics of human and veterinary importance.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of Probion Forte® (Bacillus subtilis KCCM
10941P and Bacillus coagulans KCCM 11093P) as a feed additive. The technical dossier was prepared
following the provisions of Article 7 of Regulation (EC) No 1831/2003, Regulation (EC) No 429/20085
and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agent in animal feed. The Executive Summary of the EURL
report can be found in Annex A.6
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Probion Forte®
is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 WooGene B&G Co. Ltd., represented in the EU by Agencja Inwestycyjno, Wojska Polskiego 65, 82 – 825, Bydgoszcz, Poland.
3 Technical dossier/Supplementary information February 2016/Administrative documents/CoIdentity.
4 FEED dossier reference: FAD-2014-0038.
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
6 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnirep-fad-2014-0038-probion-forte.pdf
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documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Guidance on studies
concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012b), Guidance
on the assessment of the toxigenic potential of Bacillus species used in animal nutrition (EFSA FEEDAP
Panel, 2014) and Guidance on the assessment of bacterial susceptibility to antimicrobials of human
and veterinary importance (EFSA FEEDAP Panel 2012c).
3. Assessment
Probion Forte® is a preparation of spores of B. subtilis and B. coagulans intended for use as a feed
additive to improve the performance of chickens for fattening (category: zootechnical additive;
functional group: gut ﬂora stabiliser).
3.1. Characterisation
3.1.1. Characterisation of the active agents
The B. subtilis strain was isolated from the Korean traditional fermented food Chung-gook-jang
(ground fermented soybean paste) and is deposited in the Korean Culture Center of Microorganisms
with the accession number KCCM 10941P. The B. coagulans strain (of non-speciﬁed origin) is deposited
in the same culture collection with the accession number KCCM 11093P.7
The taxonomical identiﬁcation of the product strains as B. subtilis and B. coagulans was established
by analysis of the full sequence of the 16S rRNA gene.8 No methods for strain speciﬁc identiﬁcation
were provided.
Both strains were tested for antibiotic susceptibility using twofold broth dilutions. The battery of
antibiotics tested was that recommended by EFSA (EFSA FEEDAP Panel 2012c).9 All minimum
inhibitory concentration (MIC) values for the two strains were equal or fell below the corresponding
cut-off values deﬁned by the FEEDAP Panel. Consequently, no further investigation is necessary and
the strains are considered to be susceptible to all relevant antibiotics.
A cytotoxicity study following ISO 10993-5:2009 (Biological Evaluation of Medical Devices, Part 5:
Tests for in vitro Cytotoxicity) was provided using ﬁbroblast cells.10 However, the Panel considered that
this study is unacceptable as a means of excluding the toxigenic potential due to a series of
deﬁciencies (e.g. unknown test item, inappropriate negative and positive controls, inappropriate cell
line).
3.1.2. Production process and characterisation of the additive
The two organisms are produced separately using typical industrial media containing sucrose and
starch as sugar sources, yeast extract and salts. After sporulation, the fermentation broth is
concentrated and the resulting slurry is spray-dried. After drying, the spores are mixed in the
appropriate proportion and blended with carriers (zeolite (25%) and diatomite (51%)).
Probion Forte® is a 1:1 mixture of the two active agents, B. subtilis (KCCM 10941P) and B. coagulans
(KCCM 11093P) with a minimum content of spores of each strain of 1 9 108 colony-forming units (CFU)/g
additive.
Analysis of ﬁve batches of the additive showed compliance with speciﬁcations (mean:
1.6 9 108 CFU B. subtilis/g and 1.3 9 108 CFU B. coagulans/g; range: 1.2–2.0 9 108 CFU B. subtilis/g
and 1.2–1.4 9 108 CFU B. coagulans/g).11
The applicant set speciﬁcations for some microbial and chemical contaminants (absence of
Salmonella, Shigella and Staphylococcus, absence of mycotoxins, lead < 20 mg/kg, mercury < 1 mg/kg,
arsenic < 5 mg/kg and chromium < 100 mg/kg).12 Analysis of three batches showed values compliant
with these speciﬁcations and that do not give rise for concerns (lead ≤ 2.33 mg/kg, arsenic ≤ 4.31 mg/kg,
7 Technical dossier/Supplementary information July 2016/Section II/C1/KCCM11093P.
8 Technical dossier/Supplementary information July 2016/Section II/C1/1,2,3_taxonomic identiﬁ_morphological_susceptibility
and COA_Molecular analysis.
9 Technical dossier/Supplementary information July 2016/Section II/C2/Test on susceptibility to antimicrobials.
10 Technical dossier/Supplementary information July 2016/Section II/C2/Study on Safety of Probiotic combination of
Bacillus subtilis and Test report cytotoxicity test.
11 Technical dossier/Supplementary information February 2016/Section II/Annex II_9.
12 Technical dossier/Supplementary information February 2016/Section II/Annex II_10.
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chromium < 5 mg/kg, mercury, mycotoxins, Salmonella, Shigella and Staphylococcus were not
detected).13,14 The action limit set for chromium is high; however, the Panel notes that analysis of the
additive the batches tested provided values that do not give rise to concerns.
The additive is described as a light red or brown powder. One batch was examined for particle size
distribution by laser diffraction.15 Results showed that approximately 66% by volume of the additive
consists of particles with diameters below 50 lm and 14% below 10 lm. The total aerosol mass using
the National Institute of Occupational Safety and Health Test Method 0500 was determined in one
batch and found to be 0.45 mg/m3. The test was performed in the mixing and packing area of the
plant during one rotation which is equivalent to 8 h shift.
3.1.3. Stability and homogeneity
To study the shelf-life of Probion Forte®, three batches were stored in its commercial packaging at
25°C/60% relative humidity (RH) and 40°C/75% RH and B. subtilis and B. coagulans counts measured
at 24 and 6 months, respectively.16 Individual counts of the two species remained constant
(losses < 0.5 log) under both tested conditions.
Stability of three batches of Probion Forte® when mixed at the recommended dose with a minerals/
vitamins premixture, mash feed and pelleted feed for chickens was tested at 25°C/60% RH for
6 months.16 No signiﬁcant differences were observed in the enumeration of the two species in any of
the tested materials (losses < 0.5 log). No information on the stability of the additive to pelleting was
provided.
The ability of the additive (one batch) to be uniformly distributed in a minerals/vitamins premixture
and a mash feed for chickens was examined.16 Analyses of individual counts of 10 subsamples showed
a coefﬁcient of variation of 2% (for both bacterial species) in premixtures and of 3% (B. subtilis) and
2% (B. coagulans) in feed.
3.1.4. Conditions of use
The additive is intended for use in feed for chickens for fattening at the minimum recommended
dose 1 9 108 CFU/kg feedingstuffs (equivalent to 500 mg/kg feedingstuffs) and a maximum dose of
2 9 108 CFU/kg feedingstuffs (equivalent to 1,000 mg/kg feedingstuffs).
3.2. Safety
In the view of the FEEDAP Panel, the identity of the bacterial strains is established as B. subtilis
and B. coagulans and their susceptibility to relevant antibiotics demonstrated. However, both bacterial
strains belong to species capable of producing toxins. The absence of a toxigenic potential has not
been demonstrated and, therefore, these strains do not qualify for a QPS approach to safety
assessment and separate studies on target animals and consumer safety are required.
3.2.1. Safety for chickens for fattening
Two studies were presented to support the safety of Probion Forte® for chickens for fattening.
Neither could be further considered due to inadequate reporting and ﬂaws in the study design (i.e. in
one case, no information on housing conditions of chickens was provided and the study lacked
replication,17 and in the second case, no overdose was included18). Therefore, in the lack of data, the
FEEDAP Panel cannot conclude on the safety of the additive for the target species.
3.2.2. Safety for the consumer
Both bacterial strains belong to species of Bacillus capable of producing toxins. The spores will
survive passage through the gastrointestinal tract of animals and be a potential source of
contamination of the food of animal origin. In the absence of evidence that the two strains are not
13 Technical dossier/Supplementary information February 2016/Section II/Additional information/Reply to SIn May 22.
14 Limits of detection not speciﬁed.
15 Technical dossier/Supplementary information July 2016/Section II/C4/Particle size and dusting potential.
16 Technical dossier/Supplementary information July 2016/Section II/C5/Stability and homogeneity.
17 Technical dossier/Section III and Section IV/3.1.2 and 4.1.3/Annex_IV_24_4.1.3.
18 Technical dossier/Section IV/Annex_IV_23_4.1.3.
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toxigenic, and given the potential for carcass contamination, safety for the consumers cannot be
established.
3.2.3. Safety for the user
A study of acute dermal irritation was performed with two batches of Probion Forte®, using three
female New Zealand White rabbits and following a protocol that conformed to OECD Guideline 404.19
No reactions were seen in any of the animals after 72 h; thus, it is concluded that the additive is not a
skin irritant.
A study of acute eye irritation was performed with two batches of Probion Forte®, using three male
New Zealand White rabbits and following a protocol that conformed to OECD Guideline 405.20 The test
item did not produce any effects on the cornea, iris or conjunctiva. Therefore, the additive is not an
eye irritant.
Skin sensitisation potential was not studied. Therefore, in the absence of data, no conclusion can
be drawn on the skin sensitisation potential.
A fraction (66%) of the particles of the product has the potential to reach the respiratory surface of
the lungs when inhaled. In the absence of evidence that the two active agents are not toxigenic and
given their proteinaceous nature, the additive should be considered a hazard for those handling it in
the feed production site.
Conclusions on safety for the user
Probion Forte® is not a skin or eye irritant but should be considered a potential respiratory
sensitiser. No conclusion can be drawn on the skin sensitisation potential. In the absence of evidence
that the two active agents are not toxigenic, Probion Forte® is considered as a hazard for those
handling the additive.
3.2.4. Safety for the environment
The strains composing the additive belong to species which are ubiquitous soil saprophytes.
Consequently, use of the strains in animal nutrition is not expected to measurably increase their
numbers in the environment. Therefore, its use as a feed additive is considered safe for the
environment.
3.3. Efﬁcacy for chickens for fattening
Six studies were provided to support the efﬁcacy of Probion Forte® when administered to chickens
for fattening. Of them, two were not further considered since they lacked replication.21,22 The
reporting of the other four studies did not allow the Panel to properly assess their suitability to
demonstrate efﬁcacy. For instance, relevant information on the statistical analysis performed and the
raw data were missing in all cases.23,24 Furthermore, in two of these, there was no clear indication of
replication.25,26 In the course of the assessment, the applicant was requested to complete the
information necessary to carry out a full assessment of the studies. However, the replies provided did
not address the concerns expressed. As a consequence, the FEEDAP Panel is not in the position to
conclude on the efﬁcacy of Probion Forte® for chickens for fattening.
19 Technical dossier/Supplementary information July 2016/Section III/C6/Acute dermal irritation study.
20 Technical dossier/Supplementary information July 2016/Section III/C6/Acute eye irritation study.
21 Technical dossier/Section III and Section IV/3.1.2 or 4.1.3 Test on Tolerance for Probion Forte®/Annex_IV_24_4.1.3.
22 Technical dossier/Sections III and IV/Annexes III_3.1.2 and IV_23 and Supplementary information July 2016/C7/Study on the
effectiveness of probiotic Probion Forte® and Supplementary information November 2016/Final supplementary information.
23 Technical dossier/Section IV/Annex IV_24 and Supplementary information July 2016/Files/Technical dossier/Section IV/C8/
Report Probion and Supplementary information November 2016/Final supplementary information.
24 Technical dossier/Section IV/4.1.5. Effects of Probion Forte® Supplementation on Growth Performance in chickens for
fattening -Growth Performance in Broiler Chickens, Annex IV_25 and Supplementary information July 2016/Files/Technical
dossier/Section IV/C7/Effect on supplementation and Supplementary information November 2016/Question 4.
25 Technical dossier/Section IV/4.1.1. Tests for possible use the Probion Forte® probiotic in chickens for fattening feeding,
Annex_IV_22_4.1.2 and Supplementary information July 2016/Files/Technical dossier/Section IV/C7/Report 1 and Supplementary
information November 2016/Annexes.
26 Techical dossier/Section IV/4.1.2. Tests for possible use the Probion Forte® probiotic in chickens for fattening feeding and
Annex_IV_21_4.1.1 and Supplementary information July 2016/Files/Technical dossier/Section IV/C7/Report 2 and Supplementary
information November 2016/Annexes.
Probion Forte® for chickens for fattening
www.efsa.europa.eu/efsajournal 7 EFSA Journal 2017;15(4):4759
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation27 and Good
Manufacturing Practice.
4. Conclusions
In the view of the FEEDAP Panel, the identity of the bacterial strains is established as B. subtilis
and B. coagulans and their susceptibility to relevant antibiotics demonstrated. However, both bacterial
strains belong to species capable of producing toxins. The absence of a toxigenic potential has not
been demonstrated and, therefore, these strains do not qualify for a QPS approach to safety
assessment and separate studies on target animals and consumer safety are required.
The data provided did not allow concluding on the safety for chickens for fattening or the
consumers.
Probion Forte® is not a skin or eye irritant but should be considered a potential respiratory sensitiser.
No conclusion can be drawn on the skin sensitisation potential of the additive. In the absence of evidence
that the two active agents are not toxigenic, Probion Forte® is considered as a hazard for those handling
the additive.
Probion Forte® is considered safe for the environment. The FEEDAP Panel is not in the position to
conclude on the efﬁcacy of Probion Forte® for chickens for fattening from the data provided.
Documentation provided to EFSA
1) Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P).
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2) Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P).
Supplementary information. February 2016. Submitted by WooGene B&G Co. Ltd.,
represented in the EU by Agencja Inwestycyjno.
3) Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P).
Supplementary information. July 2016. Submitted by WooGene B&G Co. Ltd., represented in
the EU by Agencja Inwestycyjno.
4) Probion Forte® (Bacillus subtilis KCCM 10941P and Bacillus coagulans KCCM 11093P).
Supplementary information. November 2016. Submitted by WooGene B&G Co. Ltd.,
represented in the EU by Agencja Inwestycyjno.
5) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Probion Forte®.
6) Comments from Member States.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Probion Forte®
In the current application authorisation is sought under Article 4(1) for Probion Forte®, under the
“category”/”functional group” 4(b), “zootechnical additives”/”gut ﬂora stabilisers”, according to the
classiﬁcation system of Annex I of Regulation (EC) No 1831/2003. Speciﬁcally, authorisation is sought
for the use of the feed additive for laying hens, and chickens for fattening and reared for laying.
According to the Applicant, the product is intended to be marketed as a light red or brown powder
containing at least 1 9 108 Colony Forming Units (CFU)/g of Bacillus subtilis (KCCM 10941P), and at
least 1 9 108 CFU/g of Bacillus coagulans (KCCM 11093P), on a zeolite-diatomite carrier. The feed
additive is intended to be used directly in feedingstuffs at a minimum/maximum content of 0.5/1.0 g/kg
of Probion Forte® in feedingstuffs. Taking into account (i) the content of the microorganisms in the
product and (ii) the conditions of use suggested for the product in the feed, the content of the sum of
both microorganisms in feedingstuffs would range from 1 9 108 to 2 9 108 CFU/kg.
For the identiﬁcation of Bacillus subtilis (KCCM 10941P) and Bacillus coagulans (KCCM 11093P), the
EURL recommends for ofﬁcial control Pulsed Field Gel Electrophoresis (PFGE), a generally recognised
standard methodology for genetic identiﬁcation.
For the enumeration of the sum of Bacillus subtilis (KCCM 10941P) and Bacillus coagulans (KCCM
11093P) in the feed additive and feedingstuffs the Applicant applied a spread plate procedure based
on the ISO 6887-1. The EURL identiﬁed instead the ring-trial validated spread plate method EN 15784,
already evaluated by EURL in the frame of previous Bacillus spp. dossiers. Based on the performance
characteristics available, the EURL recommends for ofﬁcial control this CEN method (EN 15784) for the
enumeration of the sum of the two microorganisms in the feed additive and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
Probion Forte® for chickens for fattening
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